August 20, 2017 3:14 AM ET

Pharmaceuticals

Company Overview of Daiichi Sankyo Propharma Co., Ltd.

Key Executives for Daiichi Sankyo Propharma Co., Ltd.

NameBoard RelationshipsTitleAge
Tsutomu Shimizu 4 RelationshipsPresident and Director--
Masamichi Katayama 4 RelationshipsExecutive Vice President and Director--
Katsuhiko Nagao 4 RelationshipsGeneral Manager of Technology Department and Director--
Yoshinobu Ohshima 4 RelationshipsGeneral Manager of Onahama Plant and Director--

Daiichi Sankyo Propharma Co., Ltd. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Tsutomu Shimizu 4 RelationshipsDaiichi Sankyo Propharma Co., Ltd.--
Katsuhiko Nagao 4 RelationshipsDaiichi Sankyo Propharma Co., Ltd.--
Masamichi Katayama 4 RelationshipsDaiichi Sankyo Propharma Co., Ltd.--
Yoshinobu Ohshima 4 RelationshipsDaiichi Sankyo Propharma Co., Ltd.--
Katsumi Fujimoto Ph.D. 18 RelationshipsDaiichi Sankyo Company, Limited62
View All Board Members

Daiichi Sankyo Propharma Co., Ltd. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
423.3K
Bonus
425.9K
Total Short Term Compensation
600.4K
Total Value of Options
8.2M
Compensation as of Fiscal Year
Daiichi Sankyo Propharma Co., Ltd. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Sunzen Biotech Berhad Appoints Ooi Bee Hoon as Independent and Non Executive Member of Audit Committee
August 18, 2017 5:32 AM ET
Sunzen Biotech Berhad Appoints Ooi Bee Hoon as Independent and Non Executive Director
August 18, 2017 5:32 AM ET
Sunzen Biotech Berhad Appoints Ooi Bee Hoon as Independent and Non Executive Member of Nomination Committee
August 18, 2017 5:32 AM ET
Depomed, Inc. Announces Executive Appointments
August 17, 2017 8:28 PM ET
Merz Neuroscience Appoints Kevin O'Brien as Vice President and U.S. Head of Neuroscience Business
August 17, 2017 11:45 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Daiichi Sankyo Propharma Co., Ltd., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.